Navigation Links
Pfizer to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at Alzheimer's Association International Conference on Alzheimer's Disease
Date:7/8/2010

2010 highlights Pfizer's strategic approach to the discovery and development of potential new medicines as it underscores our effort to focus on a range of promising pathological targets.  We are committed to advancing the science of AD, with the ultimate goal of delivering innovative and meaningful new treatment options to patients."

The compounds in Pfizer's pipeline target many of the pathways thought to be implicated in Alzheimer's disease.  The data that will be presented at ICAD 2010 focus on several of these approaches, including:

Beta Amyloid Passive Immunotherapy: The most prominent theory currently is the beta amyloid hypothesis, which is based on evidence that the accumulation of beta amyloid, a toxic protein, is a defining characteristic of AD.  It is believed that reducing brain beta amyloid accumulation by inhibiting the production of beta amyloid and/or removing beta amyloid from the brain may slow the progression of the disease.  In passive immunotherapy, monoclonal antibodies are directed against beta amyloid facilitating removal of beta amyloid and thus reducing its accumulation in the brain.

Pfizer, together with Janssen Alzheimer Immunotherapy, its collaborator on the Alzheimer's Immunotherapy Program, is presenting a new exploratory analysis of pooled data from two Phase II studies on an investigational monoclonal antibody therapy.  Pfizer also is presenting several Phase I studies on another investigational monoclonal antibody therapy.

PDE Inhibition: The PDE enzyme family is thought to play a role in influencing synapse communication and stability, which is compromised in Alzheimer's disease.  Regulating the actions of these enzymes may potentially improve information processing, attention, memory and executive functioning.


'/>"/>
SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... -- Hearing health affects a man,s lifestyle, and if he ... professionally engaged, he should address any hearing loss he may ... Better Hearing Institute (BHI) is delivering to men around ... , which leads up to and includes Father,s Day. This ... June 16. To help men address their ...
(Date:5/23/2013)... , May 23, 2013  TeamHealth Medical ... nurse triage and nurse advice lines, announces its ... comprising physician, nursing and administrative leaders, provides clinical ... quality and cost-effective services for hospital clients, physician ... national healthcare system evolves, it,s imperative to continuously ...
(Date:5/23/2013)... DIEGO , May 23, 2013  The ... prostate cancer treatment continuum was highlighted prominently at ... American Urological Association (AUA), in San Diego.  According ... high intensity focused ultrasound (HIFU) technology, the need ... disease, and for urologists to consider minimally invasive ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6
... Access Pharmaceuticals, Inc.,(OTC Bulletin Board: ACCP) ... using the company,s proprietary Cobalamin(TM) technology, to,significantly ... of diabetes, through,its oral insulin product candidate. ... the body,s natural absorption of vitamin B12 ...
... Some 5,000 COPD patients will be tested,to ... in,a study marking a major cooperative effort between ... Care (AARC)., The principal investigator is Robert ... Medicine, National Jewish Medical and Research Center,in Denver. ...
Cached Medicine Technology:Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 2Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin 3Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3
(Date:5/24/2013)... measuring fractional flow reserve (FFR) using pressure wire ... pain leads to significant changes in the management ... from a study reported at EuroPCR 2013. , ... management strategy at coronary angiography for diagnosis of ... routine assessment of FFR in all the main ...
(Date:5/24/2013)... Beach Gardens, FL (PRWEB) May 24, 2013 ... surgeons jealous, Dr. Greg DeLange of the Estetica ... of the hosts of KOOL 105.5 FM’s popular morning show, ... the air about their experiences and their satisfaction with the ... Institute, a cutting-edge facility located in Palm Beach Gardens, very ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Electric™ Energy Straws, ... fueling IndyCar Rookie Carlos Munoz and will be the lead ... 500 at the Indianapolis Motor Speedway. Munoz, who is part ... speed of 228.342 mph in race, qualifying to be named ... the first row in Sunday’s race. , While Munoz ...
(Date:5/24/2013)... OH (PRWEB) May 24, 2013 ... provider of barcode identification, tracking and data management ... acquired Triangle Biomedical Sciences Inc., (TBS) of Durham, ... instrumentation, reagents and consumables for the clinical and ... of General Data Healthcare, which provides specialty products ...
(Date:5/24/2013)... New research presented today shows that formation of new ... for its importance in learning and remembering - could ... of existing brain circuits. Drs. Paul Frankland and ... in Toronto, argue this reorganization could have the positive ... increasing capacity for new learning. These results were ...
Breaking Medicine News(10 mins):Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3Health News:New neuron formation could increase capacity for new learning, at the expense of old memories 2
... , ... products and services provider DHS Technologies LLC recently revealed its newest shelter system – ... ... Technologies LLC recently revealed its newest shelter system – the Reeves Mobile Vaccination System., ...
... ... income in the current economy, and who are looking to better their health, too, can ... enlisting interested business leaders nationwide., , ... (PRWEB) March 16, 2010 -- Independent businessman Brad Aspin and leading health and wellness ...
... Large amounts of frozen plasma are being used inappropriately, ... Medical Association Journal ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj081933.pdf ... the clinical use of red blood cells and platelets ... of frozen plasma. "Two recent studies in Canada ...
... ... ... SAN RAFAEL, Calif. , March 15 The following was released today by the Marin Institute: , ... , , ...
... March 15 Spotlighting the importance of oral health care for expectant mothers, the California Dental Association (CDA) Foundation has released new guidelines designed to emphasize the safety of ... ... ... ...
... , March 15 The Board of Directors of Healthcare Trust of America, Inc. ("HTA"), ... June 2010 .  These distributions will be calculated based on the stockholders of record each day ... $10.00 . , ... ...
Cached Medicine News:Health News:DHS Technologies Unveils New Mobile Vaccination System 2Health News:Brad Aspin and Health and Wellness Company GBG Now Looking for Leaders Nationwide 2Health News:Advocates Rally Southland Assembly Health Committee Members to Pass AB 1694 2Health News:Advocates Rally Southland Assembly Health Committee Members to Pass AB 1694 3Health News:Advocates Rally Southland Assembly Health Committee Members to Pass AB 1694 4Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 2Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 3Health News:California Dental Association Foundation Releases New Oral Health Guidelines for Pregnant Women 4Health News:Healthcare Trust of America Board of Directors Declares Distributions 2Health News:Healthcare Trust of America Board of Directors Declares Distributions 3
Indications For Usage: ,Airway management during anesthesia or short-term surgical procedures....
Indications For Usage: , Airway management during surgical procedures. , Long-term ventilatory management. ...
Indications For Usage: , Nasal surgery. , Ophthalmic surgery. , Facial surgery. , T&A surgery. ...
Indications For Usage: ,Airway management during pediatric surgical procedures and intensive care....
Medicine Products: